Transforming the treatment of psoriasis to the 21st century: Detecting subclinical therapeutic response to secukinumab using optical coherence tomography as a prognostic indicator.
Skye FeliceMoshe Y BresslerRaisa KarimOrit MarkowitzPublished in: Lasers in surgery and medicine (2022)
ET measurements using OCT can detect an early subclinical response to secukinumab compared to clinical scoring and identify nonresponders as early as 4 weeks.